RxDoctor Payments Data

Pat Whitworth

Surgical Oncology · Nashville, TNNPI 1144205519

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $52,275 of the $61,599 with a category attached, or 84.9%. Icad, Inc accounts for 75.7% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2020 at $30,526 and has fallen 99.9% since, to $32 in 2025. Among surgical oncology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$61,599in general payments, 2019–2025

Across 87 payments — averaging $708.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Icad, Inc$47K
  • Endomagnetics Ltd$6K
  • Puma Biotechnology, Inc.$4K
  • Impedimed, Inc.$3K
  • Elucent Medical$545
  • Vector Surgical, LLC$230
  • plus $2K from 17 others
$25,900in research payments, 2019–2025

Across 4 payments — averaging $6475.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Puma Biotechnology, Inc.$21K
  • Medtronic$5K
$12,563in ownership & investment interests, 2019–2025

Across 6 payments — averaging $2093.87 each. An ownership or investment interest held by the physician or an immediate family member.

  • Viseon, Inc.$13K

What the payments were for

  • Consulting fees$52,27585%
  • Speaking & faculty fees$1,0002%
  • Travel & lodging$2,6504%
  • Food & beverage$5,3609%
  • Entertainment$3141%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$61,599 in reported general payments places this provider in the 95th percentile of 53 surgical oncology providers in Tennessee.

See all surgical oncology providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
Anastrozole109$2,546
Letrozole48$1,376

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →